Publication: 3806

Publication: 3806

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 41 (5) 1079-1091

Year:: 2023
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 12

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA233163, UG1CA189858, UG1CA233180, UG1CA233290, UG1CA233320, UG1CA233337, UG1CA233339, UG1CA189954, U10CA180863 to the Canadian Cancer Trials Group; UG1CA233234 ECOG–ACRIN ; U10CA180868 NRG Oncology; U10CA180888 SWOG

Corr. Author:
Authors:: Seohyuk Lee Chao Ma Qian Shi Pankaj Kumar Felix Couture Philip Kuebler Smitha Krishnamurthi DeQuincy Lewis Benjamin Tan Richard M. Goldberg Alan Venook Charles Blanke Eileen M. O'Reilly Anthony F. Shields Jeffrey A. Meyerhardt

Networks:: CA824, HEARTLAND, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-OH007, OH027, OR013, SCOR

Study: Alliance-A151939
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80702
Phases:: N/A, 3

Keywords:: ORIGINAL REPORTS, Gastrointestinal Cancer